Vaccination with a Replication-Dead Murine Gammaherpesvirus Lacking Viral Pathogenesis Genes Inhibits WT Virus Infection
Viruses · 2024
DOI: 10.3390/v16121930 ↗Kurz gefasst
Fachartikel in der Zeitschrift Viruses, 2024. Verfasst von Dipanwita Mitra und 3 weiteren Autor:innen. Beteiligte Einrichtung: HIV and AIDS Malignancy Branch, National Cancer Institute, Bethesda, MD 20892, USA. Hauptthemen laut MEDLINE: Virus Replication, Mice, Inbred C57BL, Herpesviridae Infections, Virus Latency. Die Arbeit nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIH HHS, NIAID NIH HHS, Intramural NIH HHS.
Abstract (Originalsprache)
Gammaherpesviruses are oncogenic pathogens that establish lifelong infections. There are no FDA-approved vaccines against Epstein–Barr virus or Kaposi sarcoma herpesvirus. Murine gammaherpesvirus-68 (MHV68) infection of mice provides a system for investigating gammaherpesvirus pathogenesis and testing vaccine strategies. Prime-boost vaccination with a replication-dead virus (RDV) that does not express the essential replication and transactivator protein (RTA) encoded by ORF50 (RDV-50.stop) protected against WT virus replication and reduced latency in C57BL/6 mice, and prevented lethal disease in Ifnar1−/− mice. To further improve the RDV vaccine and more closely model KSHV vaccine design, we generated an RDV lacking the unique M1-M4 genes and the non-coding tRNA-miRNA-encoded RNAs (TMERs) 6, 7, and 8 that collectively promote latency of MHV68 in vivo. Prime-boost vaccination of mice with RDV-50.stop∆M1-M4 elicited neutralizing antibodies and virus-specific CD8 T-cell responses in the lungs and spleens, the respective sites of acute replication and latency, that were comparable to RDV-50.stop vaccination. When challenged with WT MHV68, vaccinated mice exhibited a near-complete block of lytic replication and a reduction in latency and reactivation. We conclude that the unique M1-M4 genes and TMERs 6, 7, and 8, which are major determinants of WT MHV68 pathogenesis, are not required for eliciting protective immunity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- HIV and AIDS Malignancy Branch, National Cancer Institute, Bethesda, MD 20892, USA.
- Gundersen Medical Foundation: Virology Research, La Crosse, WI 54601, USA.
- Department of Microbiology and Immunology, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA.
ORCID-Profile: Dipanwita Mitra, Laurie T Krug
Förderung
- NIH HHS
- NIAID NIH HHS
- Intramural NIH HHS
- NCI NIH HHS
- NIH
Zitieren
APA
Mitra, D., Oldenburg, D. G., Forrest, J. C., & Krug, L. T. (2024). Vaccination with a Replication-Dead Murine Gammaherpesvirus Lacking Viral Pathogenesis Genes Inhibits WT Virus Infection. Viruses. https://doi.org/10.3390/v16121930
Vancouver
Mitra D, Oldenburg DG, Forrest JC, Krug LT. Vaccination with a Replication-Dead Murine Gammaherpesvirus Lacking Viral Pathogenesis Genes Inhibits WT Virus Infection. Viruses. 2024. doi:10.3390/v16121930
BibTeX
@article{Mitra2024,
author = {Mitra, Dipanwita and Oldenburg, Darby G and Forrest, J Craig and Krug, Laurie T},
title = {Vaccination with a Replication-Dead Murine Gammaherpesvirus Lacking Viral Pathogenesis Genes Inhibits WT Virus Infection},
journal = {Viruses},
year = {2024},
doi = {10.3390/v16121930}
}
EUVIMED